Helpline: 98400 69000, 04433125000
Make an Enquiry
Helpline: 98400 69000, 04433125000
    Downloads

Donate
  • About Us
    • The History
    • Our Founder
    • Our Logo
    • Governance
    • Legal Details
    • Partners
  • Services
    • Clinical Care
    • Infectious Diseases Laboratory
    • Community Outreach
  • Projects
    • YRG121
    • Camp Rainbow
    • Hepatitis C Free Chennai 2022
    • S. S. Educational Fund
    • Min Siragugal
  • Research
    • Clinical
      • Ongoing
      • Completed
  • News & Events
  • Suniti Symposium
    • 2021
  • COVID-19 Response
  • Donate
  • Contact Us
    • Contact Us
    • Join Us

Archives: Clinicals

A5175 -A Phase IV, Prospective, Randomized, Open-Label Evaluation of the Efficacy of Once-Daily Protease Inhibitor- And Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Therapy Combinations For Initial Treatment Of HIV-1 Infected Individuals From Resource-Limited Settings (PEARLS) Trial

A5199 -International Neurological Study- A Stand Alone Study for Participants of A5175 (A Phase IV, Randomized, Open-Label Evaluation of the Efficacy of Once Daily Protease Inhibitor and Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Therapy Combinations for Initial Treatment of HIV-1 Infected Individuals from Diverse Areas of the World)

A5185 -Effect of Antiretroviral treatment of Genital Compartment virus in individuals initiating Potent Antiretroviral therapy from Resource limited settings.

A5207- Maintaining Options for Mothers Study (MOMS) – A Phase II Randomized Comparison of three Antiretroviral Strategies administered for 7 or 21 days to reduce the emergence of Nevirapine resistant HIV-1 following a single Intrapartum dose of Nevirapine

A5190- Assessment of Safety and Toxicity among Infants Born To HIV-1-Infected Women Enrolled in Antiretroviral Treatment Protocols in Diverse Areas of the World – A Limited Center Trial of the Adult AIDS Clinical Trials Group (AACTG) and the Pediatric AIDS Clinical Trials Group (PACTG), Conducted in Collaboration with the HIV Prevention Trials Network (HPTN)

A5221-STRIDE -A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis with CD4 < 250 Cells/mm3

A5230- A Pilot Study of Lopinavir/Ritonavir in Participants Experiencing Virologic Relapse on NNRTI-Containing Regimens

A5271- “Collection of Comparison Neurocognitive Data in Resource-Limited Settings”

A5265/GIVEN, “A Phase III, Open-Label, Randomized, Assessment-Blinded Clinical Trial to Compare the Safety and Efficacy of Gentian Violet Oral Solution to that of Nystatin Oral Suspension for the Treatment of Oropharyngeal Candidiasis in HIV-1 Infected Participants in Non-U.S. Settings

A5273: Multicenter Study of Options for Second-Line Effective Combination Therapy (SELECT), A Multicenter Trial of the AIDS Clinical Trials Group (ACTG)

Posts navigation

Page 1 Page 2 … Page 6 Next page
Get our YRG CARE Bulletin
  • Home
  • Research
  • News & Events
  • Min Siragugal
  • Donate
  • Contact Us
  • Terms & Conditions
  • Privacy Policy
  • Refund Policy
  • Procurement Notices

Share This

Donate
Security Partner : Shieldfy

Make an Enquiry

  • max porno
  • porn videos
  • redwap in

Register